Scholars Central

Short communicationPublished 25 May 2022

Angiogenesis in Head and Neck Cancer

Authors: Denaro N

Head and Neck Cancer Research

Volume 7 · Issue 3 · Pages 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Locally advanced Head and Neck Squamous Cell Carcinoma (HNC) is a challenging disease for the lack of effective therapies even in the era of molecular medicine (the five-year survival does not exceed 40%). For patients with metastatic and recurrent HNC, the standard treatment is the combination of Cetuximab/Platinum and Fluorouracil but the median overall survival rate for this population remains lower than 11%. The main reasons for these disappointing outcomes include acquired drug resistance, anti Epidermal growth factor variants, epithelial to mesenchymal transition, and tumor hypoxia. Angiogenesis plays a crucial role in HNSCC development and proliferation. Drugs may interfere with the angiogenic process via different mechanisms and there is a sound rationale for combining anti-angiogenic agents with chemotherapy or multiple anti-angiogenic strategies. Promising preclinical results with angiogenic inhibitors have engendered a number of trials, but until now there are not yet conclusive data on the value of anti-angiogenic therapy in HNC. This paper aims to review the role of angiogenesis inhibitors in head and neck cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Head and Neck Cancer Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHead and Neck Cancer Research
  • SubjectOncology & Cancer
  • SubjectENT & Otolaryngology
  • BylineArticles whose byline prints “Denaro N”